Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$110M |
| 2 |
Willis Towers Watson
WTW
|
+$70.4M |
| 3 |
Gen Digital
GEN
|
+$63.3M |
| 4 |
Goldman Sachs
GS
|
+$53.6M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$110M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.2M |
| 3 |
Global Payments
GPN
|
+$43.3M |
| 4 |
Cardinal Health
CAH
|
+$41.2M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 14.83% |
| 3 | Healthcare | 8.61% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Synopsys
SNPS
$75.5B
| $1.81M | 0.02% |
6,033
-15,905
| -72% | -$4.83M |
|
752
CALL
Nektar Therapeutics
NKTR
$2.52B
| $1.8M | 0.02% |
+6,667
| New | +$1.6M |
|
753
Datadog
DDOG
$81.1B
| $1.79M | 0.02% |
+12,700
| New | +$1.6M |
|
754
Incyte
INCY
$25.9B
| $1.79M | 0.02% |
+26,043
| New | +$1.98M |
|
|
GCAC
755
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
| $1.79M | 0.02% |
181,101
+168,257
| +1,310% | +$1.65M |
|
756
Senti Biosciences Holdings
SNTI
$11.8M
| $1.79M | 0.02% |
17,990
-2,004
| -10% | -$198K |
|
757
Kulicke & Soffa
KLIC
$4.37B
| $1.78M | 0.02% |
+30,600
| New | +$1.91M |
|
758
Becton Dickinson
BDX
$52B
| $1.76M | 0.02% |
7,341
-757
| -9% | -$186K |
|
759
Fortive
FTV
$18.3B
| $1.76M | 0.02% |
+33,064
| New | +$1.81M |
|
760
Dolby
DLB
$6.19B
| $1.75M | 0.02% |
19,900
-61,326
| -76% | -$5.94M |
|
761
SolarEdge
SEDG
$1.85B
| $1.75M | 0.02% |
6,600
-2,469
| -27% | -$672K |
|
762
Vulcan Materials
VMC
$35.8B
| $1.74M | 0.02% |
+10,300
| New | +$1.84M |
|
763
VanEck Oil Services ETF
OIH
$1.94B
| $1.74M | 0.02% |
+8,844
| New | +$1.68M |
|
764
AptarGroup
ATR
$8.57B
| $1.74M | 0.02% |
14,558
+8,958
| +160% | +$1.18M |
|
765
Xylem
XYL
$26.7B
| $1.73M | 0.02% |
14,000
+6,500
| +87% | +$836K |
|
766
Thor Industries
THO
$4.13B
| $1.73M | 0.02% |
+14,100
| New | +$1.61M |
|
767
Xcel Energy
XEL
$48.3B
| $1.73M | 0.02% |
27,692
-130,108
| -82% | -$8.79M |
|
|
EJFA
768
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
| $1.73M | 0.02% |
+175,000
| New | +$1.7M |
|
769
MGIC Investment
MTG
$6.38B
| $1.71M | 0.02% |
113,966
+24,910
| +28% | +$361K |
|
|
VISN
770
CALL
Vistance Networks Inc
VISN
$2.5B
| $1.7M | 0.02% |
+125,000
| New | +$2.15M |
|
771
ScottsMiracle-Gro
SMG
$3.53B
| $1.7M | 0.02% |
11,600
+1,900
| +20% | +$311K |
|
772
HDFC Bank
HDB
$121B
| $1.7M | 0.02% |
46,400
-18,200
| -28% | -$675K |
|
|
AJRD
773
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.69M | 0.02% |
38,900
-82,590
| -68% | -$3.69M |
|
774
Asbury Automotive
ABG
$3.79B
| $1.69M | 0.02% |
8,600
-49,239
| -85% | -$9.28M |
|
775
A.O. Smith
AOS
$8.52B
| $1.69M | 0.02% |
+27,685
| New | +$1.93M |
|
Similar funds
Steve Schonfeld's Q3 2021 Portfolio in Review
As of Q3 2021, Steve Schonfeld held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steve Schonfeld deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.
- Steve Schonfeld's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
- Steve Schonfeld added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
- Steve Schonfeld's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
- Steve Schonfeld fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
- Steve Schonfeld's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
- Steve Schonfeld opened 807 new positions and closed 588 in Q3 2021.
- Steve Schonfeld's portfolio value rose 3% quarter-over-quarter to $9.68B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.